On the cancer side, I think that's really frankly where blood gives us the least insight. Until companies like Grail have fully functioning liquid biopsies where you're looking at, I think Grail's probably looking mostly at RNA and DNA. Other companies have looked at circulating proteins. But until these liquid biopsies are there, we don't really have much insight into it. Also, virtually every cancer is a result of a somatic mutation, not a germline mutation. So knowing your genotype doesn't really help outside of a few outlier things like BRCA or Lynch.